SCHEMBL31639786

SCHEMBL31639786

CC(C)n1nc(-c2noc(C3CC3)c2-c2ncc(C3CCN(C(=O)OC(C)(C)C)CC3)cn2)c2c(N)ncnc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RET P07949 18/20 0.48
▸ KDR P35968 3/20 0.46
▸ HCK P08631 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ FGR P09769 1/20 0.46
▸ RPS6KB1 P23443 1/20 0.46
▸ FLT4 P35916 1/20 0.46
▸ MAP2K2 P36507 1/20 0.46
▸ MAP2K1 Q02750 1/20 0.46
▸ RPS6KA1 Q15418 1/20 0.46
▸ PIK3CD O00329 2/20 0.45
▸ ABL1 P00519 2/20 0.45
▸ EGFR P00533 2/20 0.45
▸ PIK3CA P42336 2/20 0.45
▸ PIK3CG P48736 2/20 0.45
▸ PRKDC P78527 2/20 0.45
▸ PI4KB Q9UBF8 2/20 0.45
▸ SRC P12931 1/20 0.45
▸ PIK3CB P42338 1/20 0.45
▸ MTOR P42345 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31640364 0.93 RET (0.42) RETKDRHCKCYP1A2FGR
SCHEMBL31640100 0.92 RET (0.44) RETKDRHCKCYP1A2FGR
SCHEMBL31639260 0.90 RET (0.43) RETKDRHCKCYP1A2FGR
SCHEMBL31639932 0.90 RET (0.44) RETKDRHCKCYP1A2FGR
SCHEMBL31639990 0.89 TGFBR1 (0.41) RETKDRHCKPIK3CDABL1
SCHEMBL31641202 0.89 RET (0.52) RETKDRHCKCYP1A2FGR
SCHEMBL31640192 0.89 RET (0.48) RETKDRHCKCYP1A2FGR
SCHEMBL31639974 0.89 RET (0.47) RETKDRHCKPIK3CDABL1
SCHEMBL31639713 0.88 RET (0.47) RETKDRHCKCYP1A2FGR
SCHEMBL31639536 0.88 RET (0.46) RETKDRHCKCYP1A2FGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025137605-A1 COMPOUNDS FOR TARGETED DEGRADATION OF PROTO-ONCOGENE TYROSINE PROTEIN KINASE RECEPTOR C4 THERAPEUTICS, INC. (US) 2025-06-26 — — WO disclosed
Send feedback